amifampridine has been researched along with Amnesia-Memory Loss in 1 studies
Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of three K(+) channel blockers, 4-aminopyridine, 3, 4-diaminopyridine and apamin, on scopolamine- or electroconvulsive shock-induced amnesia were investigated in mice by using a one-trial step-down passive avoidance system." | 3.70 | The effects of some K(+) channel blockers on scopolamine- or electroconvulsive shock-induced amnesia in mice. ( Aksu, F; Baysal, F; Inan, SY, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inan, SY | 1 |
| Aksu, F | 1 |
| Baysal, F | 1 |
1 other study available for amifampridine and Amnesia-Memory Loss
| Article | Year |
|---|---|
The effects of some K(+) channel blockers on scopolamine- or electroconvulsive shock-induced amnesia in mice.
Topics: 4-Aminopyridine; Amifampridine; Amnesia; Animals; Apamin; Avoidance Learning; Electroshock; Male; Mi | 2000 |